SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,640.00    -10.00 (-0.18%)
Bid:
5,640.00
Ask:
5,670.00
Spread: 30.00 (0.532%)
Market Cap: £3.02b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Fourth Quarter Trading Statement

9 Apr 2015 07:00

RNS Number : 6674J
Cranswick PLC
09 April 2015
 

09 April 2015

Cranswick plc

("Cranswick" or "the Company" or "the Group")

 

Trading statement for the year ended 31 March 2015

 

Cranswick issues the following update on trading for the year ended 31 March 2015. Cranswick expects to announce its full year results on 18 May 2015.

 

Current trading

 

The Group finished the year with a strong final quarter. Underlying volumes were 4 per cent ahead of the corresponding quarter a year ago. With lower input prices being passed on to customers this gave rise to a 1 per cent increase in underlying* sales. Full year underlying* sales were in line with those of a year earlier. Total sales in the final quarter were 4 per cent higher and 1 per cent higher for the full financial year. Export sales to non-European markets continued to grow with full year volumes increasing strongly compared to the previous year.

 

The Group invested £25 million in its infrastructure during the year ended 31 March 2015, generating further operational efficiencies and ensuring the ongoing provision of state of the art processing and production facilities. The extension to the Milton Keynes cooked meats facility, completed earlier in the financial year, has added substantial capacity and is delivering ongoing efficiency gains. A major upgrade to the chilling system at the Norfolk primary processing facility has delivered further efficiency benefits.

 

The integration of Benson Park is progressing as anticipated and the positive performance of the business continues to be in line with the Board's expectations. The major investment programme at the site remains on track and is expected to be commissioned in the autumn of 2015.

Financial position

 

Notwithstanding the significant capital investment programme and the acquisition of Benson Park earlier in the year, strong cash generation from operating activities through the final quarter resulted in year-end net debt being substantially lower than at the end of the third quarter and similar to the level reported at the last financial year end.

 

The Group is in a strong financial position, with committed, unsecured facilities of £120 million which provide comfortable headroom.

 

Outlook

 

The Board expects to report a trading performance for the year ended 31 March 2015 in line with its expectations. With experienced management at all levels of the Group, a strong range of products, a well-invested asset base and a robust financial position, the Board remains confident in the continued long-term success and development of the business.

 

Enquiries:

 

Cranswick plc

+44 (0)1482 372 000

Mark Bottomley, Finance Director

Powerscourt

+44 (0)20 7250 1446

Nick Dibden / Sophie Moate / Sam Trillwood

cranswick@powerscourt-group.com

 

 

 

 

 

 

Notes:

1. Cranswick's activities are focused within the UK and include the processing and supply of fresh pork, sausage, bacon, cooked meats, premium British cooked poultry, charcuterie, pastry products and sandwiches. Products are primarily supplied into the UK food retail, food service and food manufacturing sectors. Results for the year to 31 March 2014 showed revenues of £995m and profit before tax of £54.8m.

2. This announcement is based on information sourced from unaudited management accounts.

3. This announcement contains certain forward looking statements with respect to the financial conditions, results of operations and businesses of Cranswick. These statements involve risk and uncertainty because they relate to events and depend upon circumstances that will occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward looking statements. Nothing in this announcement should be construed as a profit forecast.

 

* Underlying sales exclude the contribution from acquisitions in the current year and sales from the pig breeding, rearing and trading activities in both the current and prior financial years

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQVLFBEZFFBBD
Date   Source Headline
11th Mar 20257:05 amRNSDirectorship
5th Mar 20252:24 pmRNSTotal Voting Rights
3rd Mar 20253:27 pmRNSHolding(s) in Company
24th Feb 20254:54 pmRNSDirector/PDMR Shareholding
10th Feb 20252:51 pmRNSAdditional Listing
3rd Feb 202510:04 amRNSTotal Voting Rights
22nd Jan 20251:21 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSQ3 Trading Update and Acquisition of JSR Genetics
7th Jan 20254:02 pmRNSTotal Voting Rights
27th Dec 20247:00 amRNSDirector/PDMR Shareholding
11th Dec 20243:26 pmRNSHolding(s) in Company
3rd Dec 20249:53 amRNSTotal Voting Rights
26th Nov 20247:00 amRNSINTERIM RESULTS
13th Nov 202411:41 amRNSTotal Voting Rights
1st Oct 202412:46 pmRNSTotal Voting Rights
1st Oct 202412:43 pmRNSBlock Listing LTIP return
1st Oct 202412:41 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Oct 202412:38 pmRNSDirector/PDMR Shareholding
27th Sep 20247:00 amRNSHalf Year Trading Update
25th Sep 20243:19 pmRNSDirector/PDMR Shareholding
16th Sep 202411:56 amRNSHolding(s) in Company
16th Sep 202411:55 amRNSHolding(s) in Company
12th Aug 202412:15 pmRNSDirector/PDMR Shareholding
6th Aug 20244:20 pmRNSDirector/PDMR Shareholding
5th Aug 202412:18 pmRNSDirector/PDMR Shareholding
5th Aug 202412:16 pmRNSDirector/PDMR Shareholding
5th Aug 202412:15 pmRNSDirector/PDMR Shareholding
5th Aug 202412:11 pmRNSDirector/PDMR Shareholding
1st Aug 202410:52 amRNSTotal Voting Rights
29th Jul 20244:02 pmRNSAGM Statement
29th Jul 20247:00 amRNSFirst quarter trading statement
3rd Jun 20249:42 amRNSTotal Voting Rights
21st May 20247:00 amRNSPreliminary Results
15th May 20245:22 pmRNSDirector/PDMR Shareholding
2nd May 20249:26 amRNSTotal Voting Rights
2nd Apr 20241:55 pmRNSBlock listing Interim Review
2nd Apr 20241:54 pmRNSBlock listing Interim Review
2nd Apr 20241:50 pmRNSTotal Voting Rights
27th Mar 20249:58 amRNSDirector/PDMR Shareholding
21st Mar 20241:57 pmRNSDirector/PDMR Shareholding
21st Mar 20241:55 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSDirectorate Change
15th Mar 20243:58 pmRNSDirector/PDMR Shareholding
4th Mar 20249:58 amRNSTotal Voting Rights
14th Feb 202410:11 amRNSDirector/PDMR Shareholding
14th Feb 202410:11 amRNSDirector/PDMR Shareholding
2nd Feb 202411:00 amRNSTotal Voting Rights
18th Jan 20247:00 amRNSThird quarter trading statement
3rd Jan 20247:00 amRNSDirector/PDMR Shareholding
2nd Jan 20243:05 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.